Closing the data loop in AI-driven drug discovery
Quick summary
Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage. Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law. Today, bringing a new drug to market takes an average of 10-15 years and costs…
Key takeaways
- Drug discovery is a high-cost, high-risk endeavor that is under growing pressure from a market increasingly defined by first-mover advantage.
- Since the 1950s, the cost of developing new pharmaceuticals has roughly doubled every nine years—a phenomenon known as Eroom’s Law.
- Today, bringing a new drug to market takes an average of 10-15 years and costs…
Why it matters
The significance is not only the legal text but how it changes product design. Decisions around “Closing the data loop in AI-driven drug discovery” may reshape data collection, model training, output accountability and market access.
